CAS 18583-89-6

methyl 3-amino-2-methylbenzoate

Codes：LENA-014

Application context (from source-drug indications)

边缘带B细胞淋巴瘤来那度胺滤泡性淋巴瘤来那度胺成人T细胞白血病淋巴瘤来那度胺套细胞淋巴瘤来那度胺骨髓增生异常综合征来那度胺多发性骨髓瘤来那度胺

Source drugs (routes using this intermediate)

Drug	Tier	Expiry
来那度胺Lenalidomide	Tier B — Position early	-

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

来那度胺工艺路线steps: 5total yield: 63 g

3-amino-2-methylbenzoic acid→methyl 3-amino-2-methylbenzoate→methyl 3-((tert-butoxycarbonyl)amino)-2-methylbenzoate→methyl 2-(bromomethyl)-3-((tert-butoxycarbonyl)amino)benzoate→3-aminopiperidine-2,6-dione hydrochloride→tert-butyl (2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-4-yl)carbamate

Intermediates available on this site

Side-by-side comparison of all listed offers on this CAS; price bands are list-price ranges, final price subject to RFQ confirmation.

Supplier	Product	Price band	MOQ	Lead time	Qualifications
Qualified Partner — East China API Works	methyl 2-(bromomethyl)-3-nitrobenzoate Pharmaceutical Intermediates	询价	询价	询价	—
Unibest Nantong cGMP Site	3-aminopiperidine-2,6-dione hydrochloride Pharmaceutical Intermediates	询价	询价	询价	—

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.